Zenas Biopharma Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FMR LLC | 02/17/2026 | 7.70 M | $279.74 M | 59.83% | 18.27% |
| SR ONE CAPITAL MANAGEMENT, LP | 02/12/2026 | 5.04 M | $182.92 M | 2.57% | 11.95% |
| ENAVATE SCIENCES GP, LLC | 02/17/2026 | 3.92 M | $142.30 M | 4.20% | 9.30% |
| NEA MANAGEMENT COMPANY, LLC | 02/17/2026 | 3.52 M | $127.93 M | 28.88% | 8.36% |
| FEDERATED HERMES, INC. | 02/12/2026 | 2.72 M | $98.60 M | 45.85% | 6.44% |
| FAIRMOUNT FUNDS MANAGEMENT LLC | 02/17/2026 | 2.21 M | $80.21 M | 16.71% | 5.24% |
| NVP ASSOCIATES, LLC | 02/17/2026 | 1.84 M | $66.76 M | 0.00% | 4.36% |
| BLACKROCK, INC. | 02/12/2026 | 1.77 M | $64.18 M | 43.86% | 4.19% |
| VANGUARD GROUP INC | 01/29/2026 | 1.45 M | $52.76 M | 24.97% | 3.45% |
| NOVO HOLDINGS A/S | 02/17/2026 | 1.45 M | $52.65 M | -27.50% | 3.44% |
| POLAR CAPITAL HOLDINGS PLC | 02/17/2026 | 1.06 M | $38.40 M | 100.00% | 2.51% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/17/2026 | 855.33 K | $31.06 M | -0.26% | 2.03% |
| VIVO CAPITAL, LLC | 02/13/2026 | 853.50 K | $30.99 M | -27.87% | 2.02% |
| ECOR1 CAPITAL, LLC | 02/17/2026 | 789.50 K | $28.67 M | 100.00% | 1.87% |
| ARROWMARK COLORADO HOLDINGS LLC | 02/17/2026 | 751.16 K | $27.27 M | -8.91% | 1.78% |
| PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | 02/13/2026 | 591.99 K | $21.50 M | -24.01% | 1.40% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 588.39 K | $21.37 M | 25.18% | 1.40% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 02/17/2026 | 502.08 K | $18.23 M | -13.54% | 1.19% |
| STATE STREET CORP | 02/13/2026 | 438.29 K | $15.91 M | 16.11% | 1.04% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/17/2026 | 369.25 K | $13.41 M | -1.35% | 0.88% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/17/2026 | 368.40 K | $9.21 M | 100.00% | 0.87% |
| 02/13/2026 | 321.98 K | $11.69 M | 100.00% | 0.76% | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 213.19 K | $7.74 M | 19.51% | 0.51% |
| BALYASNY ASSET MANAGEMENT L.P. | 02/17/2026 | 193.15 K | $7.01 M | 100.00% | 0.46% |
| INVESCO LTD. | 02/19/2026 | 187.97 K | $6.83 M | 28.93% | 0.45% |
| SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) | 02/12/2026 | 163.86 K | $5.95 M | 100.00% | 0.39% |
| NORTHERN TRUST CORP | 02/17/2026 | 155.37 K | $5.64 M | 16.57% | 0.37% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 02/17/2026 | 133.44 K | $4.85 M | 100.00% | 0.32% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 130.70 K | $4.75 M | 100.00% | 0.31% |
| MORGAN STANLEY | 02/13/2026 | 128.34 K | $4.66 M | 44.63% | 0.30% |
| EVERSEPT PARTNERS, LP | 02/17/2026 | 121.02 K | $4.39 M | -23.77% | 0.29% |
| CAPTION MANAGEMENT, LLC | 02/17/2026 | 85.70 K | $3.11 M | 100.00% | 0.20% |
| SUPERSTRING CAPITAL MANAGEMENT LP | 02/17/2026 | 83.35 K | $3.03 M | -13.77% | 0.20% |
| AQR CAPITAL MANAGEMENT LLC | 02/17/2026 | 78.22 K | $2.84 M | 218.17% | 0.19% |
| UBS GROUP AG | 01/29/2026 | 69.50 K | $2.52 M | 95.80% | 0.16% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 51.80 K | $1.88 M | 24.26% | 0.12% |
| NUVEEN, LLC | 02/12/2026 | 50.85 K | $1.85 M | 147.82% | 0.12% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 02/13/2026 | 50.64 K | $1.85 M | -55.04% | 0.12% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 49.16 K | $1.79 M | -31.58% | 0.12% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 47.16 K | $1.71 M | 218.46% | 0.11% |
| IKARIAN CAPITAL, LLC | 02/18/2026 | 46.80 K | $1.70 M | 100.00% | 0.11% |
| ALPS ADVISORS INC | 02/12/2026 | 44.08 K | $1.60 M | 119.92% | 0.10% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 36.80 K | $1.34 M | 264.36% | 0.09% |
| 02/17/2026 | 36.00 K | $1.31 M | 100.00% | 0.09% | |
| JANE STREET GROUP, LLC | 02/12/2026 | 35.80 K | $1.30 M | 100.00% | 0.08% |
| BARCLAYS PLC | 02/13/2026 | 34.38 K | $1.25 M | 50.28% | 0.08% |
| SWISS NATIONAL BANK | 02/12/2026 | 31.60 K | $1.15 M | 100.00% | 0.08% |
| CITADEL ADVISORS LLC | 02/17/2026 | 24.46 K | $888.11 K | 100.00% | 0.06% |
| CITADEL ADVISORS LLC | 02/17/2026 | 22.10 K | $802.45 K | 100.00% | 0.05% |
| CAPTION MANAGEMENT, LLC | 02/17/2026 | 22.00 K | $798.82 K | 100.00% | 0.05% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Zenas Biopharma Inc. institutional Ownership - FAQ's
During the previous two years, 126 institutional investors and hedge funds held shares of Zenas Biopharma Inc.. The most heavily invested institutionals were:
UBS Group AG: 367,405
iA Global Asset Management Inc.: 215,830
Nuveen, LLC: 67,770
Bank of New York Mellon Corp: 60,864
PROFUND ADVISORS LLC: 21,416
China Universal Asset Management Co., Ltd.: 13,526
98.58% of Zenas Biopharma Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 41.87 M shares in the last 24 months. This purchase volume represents approximately $1.09 B in transactions.